Improvement in complete response rate, duration of response and survival with adriamycin combination chemotherapy for non-Hodgkin lymphoma: A prognostic factor comparison of two regimens-Reference-Cited by-同舟云学术

Improvement in complete response rate, duration of response and survival with adriamycin combination chemotherapy for non-Hodgkin lymphoma: A prognostic factor comparison of two regimens

Published:1978 Issue:4 Volume:4 Page:321-331
ISSN:0098-1532
Container-title:Medical and Pediatric Oncology
language:en
Short-container-title:Med. Pediatr. Oncol.

Author:

Cabanillas Fernando,Rodriguez Victorio,Freireich Emil J.

Publisher

Wiley

Subject

Cancer Research,Oncology,Pediatrics, Perinatology and Child Health

Reference13 articles.

1. Non-Hodgkin's lymphomas. II. Single agent chemotherapy

2. Combined cyclophosphamide, vincristine, and prednisone therapy of malignant lymphoma

3. , , : Concurrent Comparisons of Three Multiple Drug Regimens in the Chemotherapy of Non-Hodgkin's Lymphoma. Proceedings of the American Society of Clinical Oncology, Abstracted. 41, 1972.

4. Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ideal dose intensity of R-CHOP in diffuse large B-cell lymphoma;Expert Review of Anticancer Therapy;2022-05-05

2. Malignant Lymphoma:;Journal of Nihon University Medical Association;2022-04-01

3. Anthracycline-containing regimens for treatment of follicular lymphoma in adults;Cochrane Database of Systematic Reviews;2013-07-07

4. Treatment of Patients With Low-Grade B-Cell Lymphoma With the Combination of Chimeric Anti-CD20 Monoclonal Antibody and CHOP Chemotherapy;Journal of Clinical Oncology;1999-01

5. Ceop Regimen in the Treatment of Advanced Low-Grade Non-Hodgkin's Lymphomas: Preliminary Report;Tumori Journal;1990-12